Molbio Diagnostics' Truenat HPV-HR Plus becomes the world's first formally validated reduced-valency HPV test, meeting WHO-IARC standards
SENS study to assess feasibility, effectiveness and family experience of introducing SMA screening into the NHS newborn screening programme
The milestone, announced from Wilmington, Delaware, is powered through additional Renewable Energy Certificates (RECs) and backed by US-sourced renewable generation
Developed by the Sudha Gopalakrishnan Brain Centre, the publicly accessible ANCHOR atlas maps over 200 brainstem structures at cellular resolution, offering new possibilities for neuroscience research and clinical applications
7.5 crore antenatal check-ups and 1.2 crore high-risk pregnancies identified under flagship programme as maternal and neonatal mortality declines
The move makes EBGLYSS the only therapy offering as few as six maintenance injections per year
Broadening access for children & patients with inhibitor-complicated hemophilia
Dengue, a mosquito-borne viral disease, is emerging as a growing public health threat across Africa
Community healthcare initiatives reach a milestone year, with services spanning 90 districts, 22 states, and over 70 lakh cumulative beneficiaries since 2006
The approved product is therapeutically equivalent to Haldol tablets of Ortho McNeil Pharmaceutical
Subscribe To Our Newsletter & Stay Updated
